KoBioLabs, Inc (KOSDAQ: 348150)
South Korea
· Delayed Price · Currency is KRW
5,220.00
+20.00 (0.38%)
Jan 22, 2025, 3:00 PM KST
KoBioLabs Revenue
KoBioLabs had revenue of 16.91B KRW in the quarter ending September 30, 2024, with 119.55% growth. This brings the company's revenue in the last twelve months to 61.29B, up 109.16% year-over-year. In the year 2023, KoBioLabs had annual revenue of 33.14B with 185.54% growth.
Revenue (ttm)
61.29B
Revenue Growth
+109.16%
P/S Ratio
1.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
100.74B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |